Valve Interstitial Cell-Specific Cyclooxygenase-1 Associated With Calcification of Aortic Valves.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
07 2020
Historique:
received: 08 02 2019
revised: 10 09 2019
accepted: 24 09 2019
pubmed: 25 11 2019
medline: 28 8 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

The molecular mechanisms underlying aortic valve calcification are poorly understood. Here, we aimed to identify the master regulators of calcification by comparison of genes in valve interstitial cells (VICs) with calcified and noncalcified aortic valves. Calcified aortic valves were surgically excised from patients with aortic valve stenosis who required aortic valve replacements. Noncalcified and calcified sections were obtained from aortic valve leaflets. Collagenase-digested tissues were seeded into dishes, and VICs adhering to the dishes were cultured for 3 weeks, followed by comprehensive gene expression analysis. Functional analyses of identified proteins were performed by in vitro calcification assays. Tissue localization was determined by immunohistochemical staining for normal (n = 11) and stenotic valves (n = 30). We found 87 genes showing greater than a twofold change in calcified tissues. Among these genes, 68 were downregulated and 19 were upregulated. Cyclooxygenase-1 (COX1) messenger RNA and protein levels were upregulated in VICs from calcified tissues. The COX1 messenger RNA and protein levels in VICs were also strongly increased by stimulation with osteoblast differentiation medium. These were VIC-specific phenotypes and were not observed in other cell types. Immunohistochemical staining revealed that COX1-positive VICs were specifically localized in the calcified area of aortic valve tissues. The VIC-specific COX1 overexpression played a crucial role in calcification by promoting osteoblast differentiation in aortic valve tissues.

Sections du résumé

BACKGROUND
The molecular mechanisms underlying aortic valve calcification are poorly understood. Here, we aimed to identify the master regulators of calcification by comparison of genes in valve interstitial cells (VICs) with calcified and noncalcified aortic valves.
METHODS
Calcified aortic valves were surgically excised from patients with aortic valve stenosis who required aortic valve replacements. Noncalcified and calcified sections were obtained from aortic valve leaflets. Collagenase-digested tissues were seeded into dishes, and VICs adhering to the dishes were cultured for 3 weeks, followed by comprehensive gene expression analysis. Functional analyses of identified proteins were performed by in vitro calcification assays. Tissue localization was determined by immunohistochemical staining for normal (n = 11) and stenotic valves (n = 30).
RESULTS
We found 87 genes showing greater than a twofold change in calcified tissues. Among these genes, 68 were downregulated and 19 were upregulated. Cyclooxygenase-1 (COX1) messenger RNA and protein levels were upregulated in VICs from calcified tissues. The COX1 messenger RNA and protein levels in VICs were also strongly increased by stimulation with osteoblast differentiation medium. These were VIC-specific phenotypes and were not observed in other cell types. Immunohistochemical staining revealed that COX1-positive VICs were specifically localized in the calcified area of aortic valve tissues.
CONCLUSIONS
The VIC-specific COX1 overexpression played a crucial role in calcification by promoting osteoblast differentiation in aortic valve tissues.

Identifiants

pubmed: 31760051
pii: S0003-4975(19)31717-5
doi: 10.1016/j.athoracsur.2019.09.085
pii:
doi:

Substances chimiques

Culture Media 0
RNA, Messenger 0
RNA, Small Interfering 0
VIM protein, human 0
Vimentin 0
Cyclooxygenase 1 EC 1.14.99.1
PTGS1 protein, human EC 1.14.99.1
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-49

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Tomohisa Sakaue (T)

Department of Cardiovascular and Thoracic Surgery, Ehime University Graduate School of Medicine, Ehime, Japan; Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Ehime, Japan. Electronic address: sakaue@m.ehime-u.ac.jp.

Mika Hamaguchi (M)

Department of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.

Jun Aono (J)

Department of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.

Koh-Ichi Nakashiro (KI)

Department of Oral and Maxillofacial Surgery, Ehime University Graduate School of Medicine, Ehime University, Ehime, Japan.

Fumiaki Shikata (F)

Department of Cardiovascular and Thoracic Surgery, Ehime University Graduate School of Medicine, Ehime, Japan; Queensland Pediatric Cardiac Service, Queensland Children's Hospital, South Brisbane, Queensland, Australia.

Natsuki Kawakami (N)

Department of Cardiovascular and Thoracic Surgery, Ehime University Graduate School of Medicine, Ehime, Japan.

Yusuke Oshima (Y)

Biomedical Optics Laboratory, Graduate School of Biomedical Engineering Tohoku University, Aramaki Aza Aoba, Aoba-ku, Sendai, Miyagi, Japan; Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, Idaigaoka, Hasama-machi, Yufu City, Oita, Japan; Oral-Maxillofacial Surgery and Orthodontics, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.

Mie Kurata (M)

Department of Pathology, Division of Analytical Pathology, Ehime University Graduate School of Medicine, Ehime, Japan; Department of Pathology, Proteo-Science Center, Ehime University, Ehime, Japan.

Daisuke Nanba (D)

Department of Stem Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.

Junya Masumoto (J)

Department of Pathology, Division of Analytical Pathology, Ehime University Graduate School of Medicine, Ehime, Japan; Department of Pathology, Proteo-Science Center, Ehime University, Ehime, Japan.

Osamu Yamaguchi (O)

Department of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.

Shigeki Higashiyama (S)

Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Ehime, Japan.

Hironori Izutani (H)

Department of Cardiovascular and Thoracic Surgery, Ehime University Graduate School of Medicine, Ehime, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH